| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA5121030 | B | Activation of GIRK1/2 channel (unknown origin) expressed in HEK293 cells incubated for 6 mins by thallium flux assay | Homo sapiens | 42 | ALA5120743 | cell-based format | Scientific Literature | |
| 2. | ALA5121031 | B | Activation of GIRK1/2 channel (unknown origin) expressed in HEK293 cells assessed as efficacy incubated for 6 mins by thallium flux assay relative to VU0466551 | Homo sapiens | 40 | ALA5120743 | cell-based format | Scientific Literature | |
| 3. | ALA5121032 | B | Activation of GIRK1/4 channel (unknown origin) expressed in HEK293 cells incubated for 6 mins by thallium flux assay | Homo sapiens | 42 | ALA5120743 | cell-based format | Scientific Literature | |
| 4. | ALA5121033 | B | Activation of GIRK1/4 channel (unknown origin) expressed in HEK293 cells assessed as efficacy incubated for 6 mins by thallium flux assay relative to VU0466551 | Homo sapiens | 40 | ALA5120743 | cell-based format | Scientific Literature | |
| 5. | ALA5121034 | A | Tmax in rat brain at 10 mg/kg, ip | Rattus norvegicus | 1 | ALA5120743 | organism-based format | Scientific Literature | |
| 6. | ALA5121035 | A | Half-life in rat brain at 10 mg/kg, ip | Rattus norvegicus | 1 | ALA5120743 | organism-based format | Scientific Literature | |
| 7. | ALA5121036 | A | AUC in rat plasma at 10 mg/kg, ip | Rattus norvegicus | 1 | ALA5120743 | organism-based format | Scientific Literature | |
| 8. | ALA5121037 | A | Plasma protein binding in human assessed as unbound fraction | Homo sapiens | 10 | ALA5120743 | cell-free format | Scientific Literature | |
| 9. | ALA5121040 | A | Stability in mouse plasma | Mus musculus | 9 | ALA5120743 | cell-free format | Scientific Literature | |
| 10. | ALA5121041 | A | Drug concentration in plasma of iv dosed rat administered as cassette dose | Rattus norvegicus | 2 | ALA5120743 | organism-based format | Scientific Literature | |
| 11. | ALA5121042 | A | Drug concentration in brain of iv dosed rat administered as cassette dose | Rattus norvegicus | 2 | ALA5120743 | organism-based format | Scientific Literature | |
| 12. | ALA5121043 | A | Ratio of drug concentration in brain to plasma of iv dosed rat administered as cassette dose | Rattus norvegicus | 2 | ALA5120743 | organism-based format | Scientific Literature | |
| 13. | ALA5121044 | A | Permeability form apical to basolateral side in human Caco-2 cells | Homo sapiens | 1 | ALA5120743 | cell-based format | Scientific Literature | |
| 14. | ALA5121045 | A | Permeability form basolateral to apical side in human Caco-2 cells | Homo sapiens | 1 | ALA5120743 | cell-based format | Scientific Literature | |
| 15. | ALA5121046 | A | Efflux ratio of permeability from basolateral to apical over apical to basolateral side in human Caco-2 cells | Homo sapiens | 1 | ALA5120743 | cell-based format | Scientific Literature | |
| 16. | ALA5121047 | A | Metabolic stability in human liver S9 fraction assessed as half-life | Homo sapiens | 1 | ALA5120743 | subcellular format | Scientific Literature | |
| 17. | ALA5121048 | A | Metabolic stability in human liver S9 fraction assessed as clearance | Homo sapiens | 1 | ALA5120743 | subcellular format | Scientific Literature | |
| 18. | ALA5121049 | B | Activation of Kv2.2 channel (unknown origin) by thallium flux assay | Homo sapiens | 1 | ALA5120743 | single protein format | Scientific Literature | |
| 19. | ALA5121050 | A | Metabolic stability in human liver S9 fraction assessed as extraction ratio | Homo sapiens | 1 | ALA5120743 | subcellular format | Scientific Literature | |
| 20. | ALA5121051 | A | Metabolic stability in human liver S9 fraction assessed as parent compound remaining measured after 60 mins | Homo sapiens | 1 | ALA5120743 | subcellular format | Scientific Literature |
The page will load shortly, Thanks for your patience!